MATTHEW WHITE: Open Payments
NPI 1649825696 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$182 in 6 payments from 3 companies in 2025. Trend: 2023 $559 · 2024 $197 · 2025 $182
Food & beverage: $182
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $89 |
| E.R. Squibb & Sons, L.L.C. | 2 | $72 |
| Novo Nordisk Inc | 1 | $22 |
Products named: INGREZZA, COBENFY, Wegovy.
Industry payments across CA — which companies pay providers there.
